- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06942858
Mechanisms of Deep Transcranial Magnetic Stimulation in Enhancing Cognitive-Behavioral Therapy for Anorexia Nervosa
May 6, 2025 updated by: Jue CHEN, Shanghai Mental Health Center
Mechanisms of Deep Transcranial Magnetic Stimulation Enhances the Efficacy of Cognitive-behavioral Therapy (CBT) by Modulating Anterior Cingulate Cortex in Patients With Anorexia Nervosa
The goal of this clinical trial is to learn if dTMS targeting the ACC can be used to rapidly and effectively treat AN.
A randomized controlled study design is adopted, in which patients with AN are divided into the CBT+dTMS treatment group and CBT+pseudostimulation group by 1:1 randomization, followed by a 6-week intervention and a half-year follow-up to clarify whether CBT combined with dTMS is superior to single CBT treatment for AN.
Study Overview
Status
Recruiting
Conditions
Detailed Description
The investigators propose hypothesis that CBT improves AN symptoms by modulating the "AN-ACC pathology network", and that high-frequency stimulation targeting the ACC by dTMS can synergize "AN-ACC pathology network" and enhance the efficacy of CBT.
In order to verify this hypothesis, a randomized controlled study design is adopted, in which patients with AN are divided into the CBT+dTMS treatment group and CBT+pseudostimulation group by 1:1 randomization, followed by 6-week intervention and a half-year follow up, to clarify the near-term and long-term efficacy and safety of the dTMS treatment.
Patients in both groups undergo fMRI examinations, complete delay discounting task (DDT) and body image task before and after each treatment session.
Symptoms, psychometrics and side effect questionnaires are followed up at baseline, week 6 (at the end of treatment), and weeks 4, 8, 12 and 24 (after completion of treatment).
This study will provide a theoretical and practical basis for the innovative combined intervention method in patients with AN, and to verify the "AN-ACC pathological network" pathomechanism of AN at multiple levels.
Study Type
Interventional
Enrollment (Estimated)
110
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jue Chen, PHD
- Phone Number: +8618017311203
- Email: chenjue2088@163.com
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200030
- Recruiting
- Shanghai Mental Health
-
Contact:
- Jue Chen, PHD
- Phone Number: +8618017311203
- Email: chenjue2088@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Inclusion Criteria:
- Female, aged 18-35 years, right handedness.
- Above primary education.
- Meet the diagnostic criteria of AN in DSM-V, and13.0 kg/m2 ≤ body mass index (BMI)<18.5 kg/m2.
- No systemic nutritional therapy, psychiatric medication or any form of psychotherapy have been received within 1 month before enrollment.
- Able to understand the nature of this study and sign an informed consent form.
Exclusion Criteria:
- Diagnosed with a DSM-5 disease other than anorexia nervosa, or at high risk of suicide, strong impulsive behavior as well as anti-social behavior.
- With severe physical or cognitive impairment.
- Not able to undergo MRI.
- Considered unsuitable for enrollment in this clinical trial for other reasons.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CBT+dTMS treatment group
CBT+dTMS treatment group has 55 patients.
Each patient receives 12 individual sessions of CBT for 50 minutes 2 times per week for 6 weeks.
dTMS intervention use real coils, targeting ACC, given 5 times per week (Monday to Friday) for 6 consecutive weeks.
|
According to national and international guidelines for the treatment of eating disorders, the basic treatment for patients is nutritional therapy, that is, regular and quantitative dietary treatment, with three regular meals followed by a snack meal 2 hours after the regular meal.
Both groups received the same nutritional treatment.
M-100 Ultimate pulsed magnetic field stimulator is used for dTMS treatment.
The coil is positioned 4 cm anterior to the scalp point and the foot motor cortex, corresponding to the ACC.
A naturally cold HF001A coil is used to obtain a greater depth of stimulation, up to about 6 cm subcortical.
The coil is an integrated coil for true and false stimulation loops.
The intervention protocol is as follows: 30 treatments are given 5 times per week (Monday to Friday) for 6 consecutive weeks.
Intervention mode: stimulation frequency 20Hz, stimulation intensity 100% RMT, number of serial pulses 50, sequence interval 20s, a total of 40 trials, 2000 pulses, stimulating the left and right ACC respectively.
Each patient receives 12 individual sessions of 50 minutes twice a week for 6 weeks.The CBT therapists are nationally registered psychotherapists with systematic professional training and uniform training in CBT for anorexia nervosa to ensure consistency.
They are also supervised by a CBT supervisor at the end of each session.
|
|
Active Comparator: CBT+pseudo-stimulation group
CBT+Pseudo-stimulation group has 55 patients.
Each patient receives 12 individual sessions of CBT for 50 minutes 2 times per week for 6 weeks.
dTMS intervention uses sham coils (with the same parameters as real dTMS and generating the same noise as real coils, but without the magnetic field).
It is given 5 times per week (Monday to Friday) for 6 consecutive weeks.
|
According to national and international guidelines for the treatment of eating disorders, the basic treatment for patients is nutritional therapy, that is, regular and quantitative dietary treatment, with three regular meals followed by a snack meal 2 hours after the regular meal.
Both groups received the same nutritional treatment.
Each patient receives 12 individual sessions of 50 minutes twice a week for 6 weeks.The CBT therapists are nationally registered psychotherapists with systematic professional training and uniform training in CBT for anorexia nervosa to ensure consistency.
They are also supervised by a CBT supervisor at the end of each session.
M-100 Ultimate pulsed magnetic field stimulator is used for dTMS treatment.
The coil is positioned 4 cm anterior to the scalp point and the foot motor cortex, corresponding to the ACC (The sham coil has the same parameters as real dTMS and generating the same noise as real coils, but without the magnetic field).
A naturally cold HF001A coil is used to obtain a greater depth of stimulation, up to about 6 cm subcortical.
The intervention protocol is as follows: 30 treatments are given 5 times per week (Monday to Friday) for 6 consecutive weeks.
Intervention mode: stimulation frequency 20Hz, stimulation intensity 100% RMT, number of serial pulses 50, sequence interval 20s, a total of 40 trials, 2000 pulses, stimulating the left and right ACC respectively.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Mass Index (BMI)
Time Frame: week 0(baseline), week 2、week4(during intervention), week 6(post-intervention), week10、18、30(follow-up)
|
Calculation: BMI = weight (kg) divided by the square of height (m)
|
week 0(baseline), week 2、week4(during intervention), week 6(post-intervention), week10、18、30(follow-up)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Eating Disorder Examination Questionnaire (EDE-Q6.0)
Time Frame: week 0(baseline), week 2、week4(during intervention), week 6(post-intervention), week10、18、30(follow-up)
|
Eating Disorder Examination Questionnaire can assess the core symptoms of eating disorders, including behavioral and psychological characteristics, and rate their frequency and intensity, which can assess the severity of the eating disorder.
It consists of 4 subscales, including dietary restriction, eating concerns, body image concerns, and weight concerns.
|
week 0(baseline), week 2、week4(during intervention), week 6(post-intervention), week10、18、30(follow-up)
|
|
Eating Disorder Inventory (EDI-II)
Time Frame: week 0(baseline), week 2、week4(during intervention), week 6(post-intervention), week10、18、30(follow-up)
|
It is a commonly used scale for assessing cognitive-behavioral symptoms of eating disorders and is used to assess the severity of eating disorders.
The scale contains 91 items divided into 8 subscales and 3 temporary subscales, including the pursuit of thinness, bulimia, body dissatisfaction, feelings of ineffectiveness, perfectionism, mistrust of others, introspection, maturity fears, abstinence, impulsive regulation and social insecurity.
|
week 0(baseline), week 2、week4(during intervention), week 6(post-intervention), week10、18、30(follow-up)
|
|
Beck Depression Inventory (BDI)
Time Frame: week 0(baseline), week 2、week4(during intervention), week 6(post-intervention), week10、18、30(follow-up)
|
The BDI consists of 21 items and assesses the patient's accompanying feelings of depression over the past 2 weeks.
|
week 0(baseline), week 2、week4(during intervention), week 6(post-intervention), week10、18、30(follow-up)
|
|
Beck Anxiety Inventory (BAI)
Time Frame: week 0(baseline), week 2、week4(during intervention), week 6(post-intervention), week10、18、30(follow-up)
|
The Beck Anxiety Inventory (BAI) is a self-rating scale used to assess a patient's anxiety symptoms.
The scale consists of 21 items, each evaluating the degree of distress caused by anxiety symptoms.
It uses a four-point scale from 1 to 4, with 1 indicating no symptoms and 4 indicating severe symptoms.
The total score ranges from a minimum of 21 to a maximum of 84, with higher scores indicating more severe anxiety symptoms.
|
week 0(baseline), week 2、week4(during intervention), week 6(post-intervention), week10、18、30(follow-up)
|
|
Self-assessed Compulsive Questionnaire for Eating Disorders (SR-YBC-EDS)
Time Frame: week 0(baseline), week 2、week4(during intervention), week 6(post-intervention), week10、18、30(follow-up)
|
The SR-YBC-EDS was developed based on the Yale-Brown Compulsive Questionnaire for Eating Disorders (YBC-EDS), consisting of two parts: the first part is a list of 65 symptomatic items, which is used to identify the subjects' obsessive-compulsive symptoms, and the second part is a list of 8 core items, which is used to assess the frequency and severity of obsessive-compulsive symptoms.
All parts contain two dimensions: preoccupation and ritual behavior.
|
week 0(baseline), week 2、week4(during intervention), week 6(post-intervention), week10、18、30(follow-up)
|
|
Body Image Tasks
Time Frame: week 0(baseline), ,week 6(post-intervention)
|
Tasks that address excessive concerns about body shape/weight include the following two parts: Body size estimation: The screen will present the above 30 body size pictures sequentially, the subjects will view the body size pictures in 4000ms, and then evaluate the body size of the body pictures in 4000ms, with a score of 1 representing "very low body weight", 4 representing "very overweight", and 4 representing "very overweight".
A score of 1 represents "very low weight" and a score of 4 represents "very overweight".
Body compare task: The screen will present the above 30 body images in turn, the subjects will have 4000ms to view their own images (with randomized distortions), and then they will have 4000ms to compare their actual body shape with the body shape in the images and assess their emotional level. 1 point represents "very calm" and 4 for "very anxious".
|
week 0(baseline), ,week 6(post-intervention)
|
|
Delay Discounting Task (DDT task)
Time Frame: week 0(baseline), week 6(post-intervention)
|
The study uses a DDT task in a food choice scenario to assess inhibitory impulses.
The task requires subjects to make a decision between choosing a small reward in the present or a large reward in the future.
Inhibition to choose a small reward in the present implies a strong intertemporal decision-making ability.
The task begins with an assessment of their hunger, willingness to eat, and emotional feelings at the moment.
Then they are asked to rate 40 pictures of food on a scale of 0 to 10 on five dimensions: familiarity, craving, positive and negative emotions, emotional intensity, and eating control.
Pictures of foods with craving scores >7 and eating control <5, as well as matched in familiarity and emotion for use in the ensuing delay discounting task.
The choice is made by pressing a button: Patients choosing to get less food immediately are given fewer coupons after the delay.
But those waiting for a period of time to get more food are given more coupons after the delay.
|
week 0(baseline), week 6(post-intervention)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jue Chen, PHD, Shanghai Mental Health Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 30, 2025
Primary Completion (Estimated)
September 30, 2028
Study Completion (Estimated)
December 31, 2028
Study Registration Dates
First Submitted
April 17, 2025
First Submitted That Met QC Criteria
April 17, 2025
First Posted (Actual)
April 24, 2025
Study Record Updates
Last Update Posted (Actual)
May 11, 2025
Last Update Submitted That Met QC Criteria
May 6, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 82471573
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Feeding and Eating Disorders
-
Meyer Children's Hospital IRCCSActive, not recruitingFeeding and Eating Disorders of ChildhoodItaly
-
Region of Southern DenmarkUniversity of Southern Denmark; JaschaFondenNot yet recruitingOther Specified Feeding or Eating Disorder | Eating Disorder NosDenmark
-
Benny Kerzner, MDAbbott NutritionWithdrawnFeeding and Eating Disorders of Childhood | Feeding DifficultiesUnited States
-
Kelly TannerCompleted
-
Universidad Francisco de VitoriaDavid Varillas Delgado; María Cristina Martincrespo-Blanco; Saray Blanco-Abril; María Gema Cid-Expósito and other collaboratorsCompleted
-
Federal University of Health Science of Porto AlegreMinistry of Health, Brazil; Fundação de Amparo à Pesquisa do Estado do Rio...CompletedFeeding and Eating Disorders of ChildhoodBrazil
-
Emory UniversityCompletedFeeding and Eating Disorders of ChildhoodUnited States
-
University of Sao Paulo General HospitalActive, not recruitingBinge Eating DisorderBrazil
-
University of OregonActive, not recruitingDepression | Parent-Child Relations | Disordered Eating Behaviors | Feeding BehaviorsUnited States
-
Children's Mercy Hospital Kansas CityThe Gerber FoundationEnrolling by invitationFeeding and Eating Disorders of Childhood | Gastrostomy | Feeding Disorder of Infancy and ChildhoodUnited States
Clinical Trials on Basic treatment
-
Fuzhou General HospitalRecruitingInfections | COVID-19 | Morality | Death, AssistedChina
-
JemincareShanghai 6th People's HospitalUnknownEfficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to GlomerulonephritisGlomerulonephritis | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3B
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Xiyuan Hospital of China Academy of Chinese Medical...Completed
-
Chinese PLA General HospitalBeijing Jishuitan Hospital; Beijing Aerospace General HospitalUnknownOsteoporosis | Osteopenia, OsteoporosisChina
-
Jieming QUCompleted
-
Harvard UniversityWeiss Family Program Fund for Research in Development Economics; Harvard Lab...Completed
-
Wanbangde Pharmaceutical Group Co., LTDSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityNot yet recruitingPostoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid HemorrhageChina
-
LI FENGCancer Institute and Hospital, Chinese Academy of Medical SciencesNot yet recruitingBreast Cancer | Acute Radiation Dermatitis | Traditional Chinese Medicine (TCM)China
-
Shanghai Mental Health CenterCompleted